Dexamethasone phosphate ophthalmic solution
Sponsors
John Kempen, Eyegate Pharmaceuticals, Inc.
Conditions
Anterior UveitisDry EyeNon-infectious, Non-necrotizing Anterior ScleritisVitrectomy
Phase 1
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
CompletedNCT01059955
Start: 2012-01-31End: 2014-02-28Updated: 2016-04-21
PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy
CompletedNCT02644694
Start: 2016-03-31End: 2016-11-30Updated: 2017-02-07
Phase 3
Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye
CompletedNCT01129856
Start: 2010-06-30End: 2011-04-30Updated: 2011-04-27
Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis
CompletedNCT02517619
Start: 2016-01-16End: 2018-05-29Updated: 2018-07-26